Matthew A. Spear - Net Worth and Insider Trading
Matthew A. Spear Net Worth
The estimated net worth of Matthew A. Spear is at least $148,101 dollars as of 2024-09-20. Matthew A. Spear is the Chief Medical Officer of Poseida Therapeutics Inc and owns about 41,485 shares of Poseida Therapeutics Inc (PSTX) stock worth over $148,101. Details can be seen in Matthew A. Spear's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew A. Spear has not made any transactions after 2021-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew A. Spear
Matthew A. Spear Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew A. Spear owns 1 companies in total, including Poseida Therapeutics Inc (PSTX) .
Click here to see the complete history of Matthew A. Spear’s form 4 insider trades.
Insider Ownership Summary of Matthew A. Spear
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PSTX | Poseida Therapeutics Inc | 2021-08-20 | Chief Medical Officer |
Matthew A. Spear Latest Holdings Summary
Matthew A. Spear currently owns a total of 1 stock. Matthew A. Spear owns 41,485 shares of Poseida Therapeutics Inc (PSTX) as of August 20, 2021, with a value of $148,101.
Latest Holdings of Matthew A. Spear
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PSTX | Poseida Therapeutics Inc | 2021-08-20 | 41,485 | 3.57 | 148,101 |
Holding Weightings of Matthew A. Spear
Matthew A. Spear Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew A. Spear has made a total of 3 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Poseida Therapeutics Inc is the sale of 4,000 shares on August 20, 2021, which brought Matthew A. Spear around $35,160.
Insider Trading History of Matthew A. Spear
- 1
Matthew A. Spear Trading Performance
Matthew A. Spear Ownership Network
Matthew A. Spear Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
Matthew A. Spear is the Chief Medical Officer of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
Matthew A. Spear Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew A. Spear. You might contact Matthew A. Spear via mailing address: C/o Poseida Therapeutics, Inc., 4242 Campus Point Court, Suite 700, San Diego Ca 92121.